U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H21F2N3OS.ClH
Molecular Weight 437.934
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZAMICASTAT HYDROCHLORIDE

SMILES

Cl.FC1=CC(F)=C2OC[C@@H](CC2=C1)N3C(=S)NC=C3CCNCC4=CC=CC=C4

InChI

InChIKey=OIXMDJZVHVPBNM-GMUIIQOCSA-N
InChI=1S/C21H21F2N3OS.ClH/c22-16-8-15-9-18(13-27-20(15)19(23)10-16)26-17(12-25-21(26)28)6-7-24-11-14-4-2-1-3-5-14;/h1-5,8,10,12,18,24H,6-7,9,11,13H2,(H,25,28);1H/t18-;/m1./s1

HIDE SMILES / InChI

Molecular Formula C21H21F2N3OS
Molecular Weight 401.473
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Zamicastat (also known as BIA 5-1058) is a dopamine β-hydroxylase (DβH) inhibitor that decreases noradrenaline and increases dopamine levels in peripheral sympathetically innervated tissues. It is known that the use of DβH inhibitors is a promising approach to treat hypertension, heart failure and cardiovascular diseases where a reduction in the sympathetic tone has beneficial effects. Zamicastat participated in phase II clinical trials in pulmonary arterial hypertension as adjuvant therapy in Austria. In addition, the drug successfully completed phase I in patients with hypertension and chronic heart failure.

Approval Year

PubMed

PubMed

TitleDatePubMed
A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates.
2016 Mar 30
Patents

Sample Use Guides

BIA 5-1058 (Zamicastat) (5, 25 and 100 mg) tablets
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 05:26:25 GMT 2023
Edited
by admin
on Sat Dec 16 05:26:25 GMT 2023
Record UNII
PXQ9G79I10
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZAMICASTAT HYDROCHLORIDE
Common Name English
2H-IMIDAZOLE-2-THIONE, 1-((3R)-6,8-DIFLUORO-3,4-DIHYDRO-2H-1-BENZOPYRAN-3-YL)-1,3-DIHYDRO-5-(2-((PHENYLMETHYL)AMINO)ETHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
(R)-5-(2-(BENZYLAMINO)ETHYL)-1-(6,8-DIFLUOROCHROMAN-3-YL)-1H-IMIDAZOLE-2(3H)-THIONE HYDROCHLORIDE
Systematic Name English
Code System Code Type Description
FDA UNII
PXQ9G79I10
Created by admin on Sat Dec 16 05:26:25 GMT 2023 , Edited by admin on Sat Dec 16 05:26:25 GMT 2023
PRIMARY
SMS_ID
100000177203
Created by admin on Sat Dec 16 05:26:25 GMT 2023 , Edited by admin on Sat Dec 16 05:26:25 GMT 2023
PRIMARY
EPA CompTox
DTXSID40160652
Created by admin on Sat Dec 16 05:26:25 GMT 2023 , Edited by admin on Sat Dec 16 05:26:25 GMT 2023
PRIMARY
CAS
1383828-47-4
Created by admin on Sat Dec 16 05:26:25 GMT 2023 , Edited by admin on Sat Dec 16 05:26:25 GMT 2023
PRIMARY
DRUG BANK
DBSALT002186
Created by admin on Sat Dec 16 05:26:25 GMT 2023 , Edited by admin on Sat Dec 16 05:26:25 GMT 2023
PRIMARY
PUBCHEM
25156755
Created by admin on Sat Dec 16 05:26:25 GMT 2023 , Edited by admin on Sat Dec 16 05:26:25 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY